Repeated treatment with the κ-opioid agonist U-69593 increases K+-stimulated dopamine release in the rat medial prefrontal cortex

Synapse

Volumn 64, Issue 12, 2010, Pages 898-904

  Fuentealba, José Antonio ^a   Gysling, Katia ^a   Andrés, María Estela ^a  

^a PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

opioid receptor; Amphetamine; Microdialysis

Indexed keywords

AMPHETAMINE; DOPAMINE; N METHYL N [7 (1 PYRROLIDINYL) 1 OXASPIRO[4.5]DEC 8 YL]BENZENEACETAMIDE; POTASSIUM; SEROTONIN;

ADRENERGIC TRANSMISSION; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL EVALUATION; DIALYSATE LEVEL; DOPAMINE RELEASE; DOPAMINERGIC NERVE CELL; MALE; MICRODIALYSIS; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT;

ANALGESICS; ANIMALS; BENZENEACETAMIDES; DOPAMINE; DRUG ADMINISTRATION SCHEDULE; MALE; POTASSIUM; PREFRONTAL CORTEX; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, OPIOID, KAPPA;

EID: 77956301050     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.20808     Document Type: Article

References (24)

1. Chefer V, Thompson AC, Shippenberg TS., 1999., Modulation of cocaine-induced sensitization by κ-opioid receptor agonists. Role of the nucleus accumbens and medial prefrontal cortex., Ann NY Acad Sci, 877:, 803-806.
2. Chefer VI, Morón JA, Hope B, Rea W, Shippenberg TS., 2000., κ-Opioid receptor activation prevents alterations in mesocortical dopamine neurotransmission that occur during abstinence from cocaine., Neuroscience, 101:, 619-627.
3. Devoto P, Flore G, Pani L, Gessa GL., 2001., Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex., Mol Psychiatry, 6:, 657-664.
4. 6 receptor antagonism potentiates the behavioral and neurochemical effects of amphetamine but not cocaine., Neuropharmacology, 42:, 170-180.
5. Fuentealba JA, Gysling K, Magendzo K, Andrés ME., 2006., Repeated administration of the selective κ-opioid receptor agonist U-69593 increases stimulated dopamine extracellular levels in the rat nucleus accumbens., J Neurosci Res, 84:, 450-459.
6. Fuentealba JA, Gysling K, Andrés ME., 2007., Increased locomotor response to amphetamine induced by the repeated administration of the selective κ-opioid receptor agonist U-69593., Synapse, 61:, 771-777.
7. 2+ channels., J Neurochem, 99:, 1197-1206.
8. Gray AM, Rawls SM, Shippenberg TS, McGinty JF., 1999., The κ-opioid agonist, U-69593, decreases acute amphetamine-evoked behaviors and calcium-dependent dialysate levels of dopamine and glutamate in the ventral striatum., J Neurochem, 73:, 1066-1074.
9. Hedou G, Homberg J, Feldon J, Heidbreder C., 2001., Expression of sensitization to amphetamine and dynamics of dopamine neurotransmission in different laminae of the rat medial prefrontal cortex., Neuropharmacology, 40:, 366-382.
10. Heijna MH, Padt M, Hogenboom F, Portoghese PS, Mulder AH, Schoffelmeer AN., 1990., Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex., Eur J Pharmacol, 181:, 267-278.
11. Izenwasser S, Acri JB, Kunko PM, Shippenberg T., 1998., Repeated treatment with the selective κ-opioid agonist U-69593 produces a marked depletion of dopamine D2 receptors., Synapse, 30:, 275-283.
12. Jentsch JD, Taylor JR., 1999., Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli., Psychopharmacology (Berl), 146:, 373-390.
13. +-8-OH-DPAT, a 5-HT1A receptor agonist, inhibits amphetamine-induced serotonin and dopamine release in rat medial prefrontal cortex., Brain Res, 743:, 357-361.
14. Maisonneuve IM, Archer S, Glick SD., 1994., U50488, a κ-opioid receptor agonist, attenuates cocaine-induced increases in extracellular dopamine in the nucleus accumbens of rats., Neurosci Lett, 181:, 57-60.
15. Paxinos G, Watson C., 2005., The rat brain in stereotaxic coordinates, compact, 6th ed., Amsterdam:, Elsevier.
16. Perry JL, Carroll ME., 2008., The role of impulsive behavior in drug abuse., Psychopharmacology (Berl), 200:, 1-26.
17. Pum M, Carey RJ, Huston JP, Müller CP., 2007., Dissociating effects of cocaine and d-lamphetamine on dopamine and serotonin in the perirhinal, entorhinal, and prefrontal cortex of freely moving rats., Psychopharmacology (Berlin), 193:, 375-390.
18. Ronken E, Mulder AH, Schoffelmeer AN., 1994., Chronic activation of μ- and κ-opioid receptors in cultured catecholaminergic neurons from rat brain causes neuronal supersensitivity without receptor desensitization., J Pharmacol Exp Ther, 268:, 595-599.
19. Shi WX, Pun CL, Zhang XX, Jones MD, Bunney BS., 2000., Dual effects of D-amphetamine on dopamine neurons mediated by dopamine and nondopamine receptors., J Neurosci, 20:, 3504-3511.
20. Shippenberg TS, Zapata A, Chefer VI., 2007., Dynorphin and the pathophysiology of drug addiction., Pharmacol Ther, 116:, 306-321.
21. Sorg BA, Davidson DL, Kalivas PW, Prasad BM., 1997., Repeated daily cocaine alters subsequent cocaine-induced increase of extracellular dopamine in the medial prefrontal cortex., J Pharmacol Exp Ther, 281:, 54-61.
22. Svingos AL, Colago EE., 2002., κ-Opioid and NMDA glutamate receptors are differentially targeted within rat medial prefrontal cortex., Brain Res, 946:, 262-271.
23. van der Meulen JA, Joosten RN, de Bruin JP, Feenstra MG., 2007., Dopamine and noradrenaline efflux in the medial prefrontal cortex during serial reversals and extinction of instrumental goal-directed behavior., Cereb Cortex, 17:, 1444-1453.
24. Zakharova E, Collins SL, Aberg M, Kumar A, Fernandez JB, Izenwasser S., 2008., Depletion of serotonin decreases the effects of the κ-opioid receptor agonist U-69593 on cocaine-stimulated activity., Eur J Pharmacol, 586:, 123-129.